Institutional & Family Asset Management, LLC Cytokinetics Inc Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$26.88 - $83.49 $241 - $751	-9 Reduced 56.25%	7 $0
Q4 2022 Feb 08, 2023	BUY	$35.77 - $51.11 $107 - $153	3 Added 23.08%	16 $0
Q1 2022 May 11, 2022	SELL	$29.74 - $46.0 $2,587 - $4,002	-87 Reduced 87.0%	13 $0
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $3,435 - $4,638	100 New	100 $5,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$761 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$610 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$503 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$403 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$335 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.88B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account